rs10886800
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000497136.6(WDR11):n.*3135G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.182 in 645,812 control chromosomes in the GnomAD database, including 12,502 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.16 ( 2435 hom., cov: 33)
Exomes 𝑓: 0.19 ( 10067 hom. )
Consequence
WDR11
ENST00000497136.6 non_coding_transcript_exon
ENST00000497136.6 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.353
Publications
11 publications found
Genes affected
WDR11 (HGNC:13831): (WD repeat domain 11) This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. This gene is located in the chromosome 10q25-26 region, which is frequently deleted in gliomas and tumors of other tissues, and is disrupted by the t(10;19) translocation rearrangement in glioblastoma cells. The gene location suggests that it is a candidate gene for the tumor suppressor locus. [provided by RefSeq, Jul 2008]
WDR11 Gene-Disease associations (from GenCC):
- hypogonadotropic hypogonadism 14 with or without anosmiaInheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Illumina
- intellectual developmental disorder, autosomal recessive 78Inheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hypogonadotropic hypogonadismInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Kallmann syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 10-120908900-G-A is Benign according to our data. Variant chr10-120908900-G-A is described in ClinVar as Benign. ClinVar VariationId is 1283844.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.324 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| WDR11 | ENST00000497136.6 | n.*3135G>A | non_coding_transcript_exon_variant | Exon 26 of 26 | 1 | ENSP00000474595.1 | ||||
| WDR11 | ENST00000605543.5 | n.*2381G>A | non_coding_transcript_exon_variant | Exon 22 of 22 | 2 | ENSP00000475076.1 | ||||
| WDR11 | ENST00000263461.11 | c.*187G>A | 3_prime_UTR_variant | Exon 29 of 29 | 1 | NM_018117.12 | ENSP00000263461.5 | |||
| WDR11 | ENST00000497136.6 | n.*3135G>A | 3_prime_UTR_variant | Exon 26 of 26 | 1 | ENSP00000474595.1 | ||||
| WDR11 | ENST00000605543.5 | n.*2381G>A | 3_prime_UTR_variant | Exon 22 of 22 | 2 | ENSP00000475076.1 |
Frequencies
GnomAD3 genomes AF: 0.157 AC: 23871AN: 152068Hom.: 2435 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
23871
AN:
152068
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.190 AC: 93840AN: 493626Hom.: 10067 Cov.: 6 AF XY: 0.188 AC XY: 49327AN XY: 262582 show subpopulations
GnomAD4 exome
AF:
AC:
93840
AN:
493626
Hom.:
Cov.:
6
AF XY:
AC XY:
49327
AN XY:
262582
show subpopulations
African (AFR)
AF:
AC:
726
AN:
13404
American (AMR)
AF:
AC:
8110
AN:
23022
Ashkenazi Jewish (ASJ)
AF:
AC:
3878
AN:
15524
East Asian (EAS)
AF:
AC:
9887
AN:
31054
South Asian (SAS)
AF:
AC:
8155
AN:
50106
European-Finnish (FIN)
AF:
AC:
4054
AN:
31738
Middle Eastern (MID)
AF:
AC:
277
AN:
2100
European-Non Finnish (NFE)
AF:
AC:
53686
AN:
299114
Other (OTH)
AF:
AC:
5067
AN:
27564
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
3680
7359
11039
14718
18398
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
464
928
1392
1856
2320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.157 AC: 23865AN: 152186Hom.: 2435 Cov.: 33 AF XY: 0.157 AC XY: 11683AN XY: 74394 show subpopulations
GnomAD4 genome
AF:
AC:
23865
AN:
152186
Hom.:
Cov.:
33
AF XY:
AC XY:
11683
AN XY:
74394
show subpopulations
African (AFR)
AF:
AC:
2279
AN:
41550
American (AMR)
AF:
AC:
4225
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
793
AN:
3468
East Asian (EAS)
AF:
AC:
1741
AN:
5158
South Asian (SAS)
AF:
AC:
770
AN:
4822
European-Finnish (FIN)
AF:
AC:
1243
AN:
10586
Middle Eastern (MID)
AF:
AC:
45
AN:
294
European-Non Finnish (NFE)
AF:
AC:
12328
AN:
67996
Other (OTH)
AF:
AC:
322
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1005
2010
3014
4019
5024
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
260
520
780
1040
1300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
856
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Aug 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.